Impact of Enteric Nervous Cells on Irritable Bowel Syndrome: Potential Treatment Options


Author: Ploutarchos Pastras1, Ioanna Aggeletopoulou1, Christos Triantos1

Affiliation: <sup>1</sup> Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras, 26504 Patras, Greece.
Conference/Journal: Microorganisms
Date published: 2024 Oct 9
Other:
 Volume ID: 12   ,  Issue ID: 10   ,  Pages: 2036   ,  Special Notes: doi: 10.3390/microorganisms12102036.   ,  Word Count: 267  
    Irritable bowel syndrome (IBS) is a condition that significantly impacts the lifestyle, health, and habits of numerous individuals worldwide. Its diagnosis and classification are based on the Rome criteria, updated periodically to reflect new research findings in this field. IBS can be classified into different types based on symptoms, each with distinct treatment approaches and some differences in their pathophysiology. The exact pathological background of IBS remains unclear, with many aspects still unknown. Recent research developments suggest that disorders in the brain-gut-microbiota axis are key contributors to the symptoms and severity of IBS. The central nervous system (CNS) interacts bidirectionally with intestinal processes within the lumen and the intestinal wall, with the autonomic nervous system, particularly the vagus nerve, playing an important role. However, the enteric nervous system (ENS) is also crucial in the pathophysiological pathway of IBS. The apeline-corticotropin-releasing factor (CRF)-toll-like receptor 4 (TLR4) signaling route via enteric glia and serotonin production in enteroendocrine cells at the enteric barrier are among the most well-understood new findings that affect IBS through the ENS. Additionally, the microbiota regulates neuronal signals, modifying enteric function by altering the number of enteric bacteria and other mechanisms. Given the limited therapeutic options currently available, it is essential to identify new treatment targets, with the brain-gut axis, particularly the enteric nervous system, being a promising focus. This study aims to delineate the molecular mechanisms that induce IBS and to suggest potential targets for future research and treatment of this potentially debilitating disease.



Keywords: central nervous system; enteric nervous cells; enteric nervous system; gut microbiota; irritable bowel syndrome; management; mechanisms; signaling.



PMID: 39458345 DOI: 10.3390/microorganisms12102036